AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

European and North Indian Cohort of KaWasaki dIsease

Recruitingn/aAges 1 Year - 17 YearsAllMeyer Children's Hospital IRCCS
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Kawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant of the long-term prognosis of these patients, as coronary aneurisms (CAAs) may lead to ischemic heart disease and even sudden death. The current standard of care for KD has consistently reduced CAAs frequency from 25-30% to about 5%. Unfortunately, 10-20% of KD patients results resistant to standard treatment leading to a major risk of cardiac complications. Thus, scoring systems have been constructed in order to identify patients likely to be resistant to IVIG and who may benefit from more aggressive initial therapy. Different scoring scales developed by Kobayashi, Egami et Sano had shown a good sensitivity (77-86%) and specificity (67-86%) in predicting IVIG unresponsiveness in Japanese populations. However, their predictive val

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients aged less than 18 years at diagnosis * Diagnosis of KD according to the AHA criteria Exclusion Criteria: * Patients who do not meet the criteria for KD * Patients for which an alternative infectious diagnosis was not investigated and/or excluded.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

27 sites
Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
Children's Hospital Zagreb
Zagreb, Croatia
University Hospital Centre Zagreb, University School of Medicine
Zagreb, Croatia
Le Kremlin-Bicetre University Hospital, Paris-Sud University - CEREMAI
Le Kremlin-Bicรชtre, France
Manipal Hospital
Bangalore, India
Postgraduate Institute of Medical Education and Research
Chandigarh, India
Sri Ramachandra Medical Centre
Chennai, India
Amrita Institute of Medical Sciences
Kochi, India

โ€ฆand 19 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy